388 related articles for article (PubMed ID: 19776103)
1. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study.
Pedersen LH; Henriksen TB; Vestergaard M; Olsen J; Bech BH
BMJ; 2009 Sep; 339():b3569. PubMed ID: 19776103
[TBL] [Abstract][Full Text] [Related]
2. Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.
Jordan S; Morris JK; Davies GI; Tucker D; Thayer DS; Luteijn JM; Morgan M; Garne E; Hansen AV; Klungsøyr K; Engeland A; Boyle B; Dolk H
PLoS One; 2016; 11(12):e0165122. PubMed ID: 27906972
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
6. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
Gentile S
Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
[TBL] [Abstract][Full Text] [Related]
7. Sertraline use during pregnancy and the risk of major malformations.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
Uguz F
Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
[No Abstract] [Full Text] [Related]
9. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors and congenital malformations.
Chambers C
BMJ; 2009 Sep; 339():b3525. PubMed ID: 19776102
[No Abstract] [Full Text] [Related]
11. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
Ban L; Gibson JE; West J; Fiaschi L; Sokal R; Smeeth L; Doyle P; Hubbard RB; Tata LJ
BJOG; 2014 Nov; 121(12):1471-81. PubMed ID: 24612301
[TBL] [Abstract][Full Text] [Related]
12. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A
JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704
[TBL] [Abstract][Full Text] [Related]
13. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
[TBL] [Abstract][Full Text] [Related]
14. SSRIs and congenital defects. Case registers in pregnancy?
Yadav DS
BMJ; 2009 Oct; 339():b4286. PubMed ID: 19846493
[No Abstract] [Full Text] [Related]
15. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
[TBL] [Abstract][Full Text] [Related]
16. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.
Alwan S; Reefhuis J; Rasmussen SA; Olney RS; Friedman JM;
N Engl J Med; 2007 Jun; 356(26):2684-92. PubMed ID: 17596602
[TBL] [Abstract][Full Text] [Related]
17. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
Singal D; Brownell M; Chateau D; Ruth C; Katz LY
BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant use in pregnancy and the risk of cardiac defects.
Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
[TBL] [Abstract][Full Text] [Related]
19. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
[TBL] [Abstract][Full Text] [Related]
20. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
